The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
Open accessAbstract
Background: microRNA (miRNA) expression profiles are being intensively investigated for their involvement in carcinogenesis. We evaluated the prognostic value of mature microRNA-21 (miR-21) and mature microRNA-205 (miR-205) overexpression in non–small cell lung cancer (NSCLC). Patients and methods: We studied 48 pairs of NSCLC fresh frozen tissue specimens collected at time of surgery and before chemotherapy. Highly specific amplification and quantification of mature miR-21 and mature miR-205 was achieved using looped real time RT-PCR. Results: miRNA expression, determined by real time RT-PCR, was defined by ΔΔCt measurements. We detected overexpression of mature miR-21 in 25 (52.0%) of the 48 NSCLC paired specimens and overexpression of miR-205 in 31 (64.6%). Overexpression was assessed after comparison of miRNA expression in NSCLC tissues and in their corresponding noncancerous tissues with respect to U6 expression. During the follow-up period, 29 of 48 (60.4%) patients relapsed, and 23 of 48 died (47.9%). Mature miR-21 was upregulated in 16 of 29 (55.2%) patients who relapsed and 15 of 23 (65.2%) patients who died. Mature miR-205 was overexpressed in 19 of 29 patients who relapsed (65.5%) and 15 of 23 patients who died (65.2%). Mature miR-21 overexpression correlated with overall survival (OS) of the patients (P = 0.027), whereas overexpression of mature miR-205 did not. Conclusions: Our results suggest that overexpression of mature miR-21 is an independent negative prognostic factor for OS in NSCLC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, miR-21 expression levels have proven useful prognostic markers in non-small cell lung cancer (Markou et al., 2008; Yanaihara et al., 2006).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Markou et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Flagged first, then by citations
Research works printed but not linked: 1
- 2006, Mol Vis, 12, 1175
Cited by
Sorted by citations
Items 101–200 of 440
MicroRNAs as a potential prognostic factor in gastric cancer
Brenner, B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i35.3976 · Cited by 88
Hulf, T., Sibbritt, T., Wiklund, E. D., Patterson, K., Song, J. Z., Stirzaker, C., Qu, W., Nair, S. S., Horvath, L. G., Armstrong, N. J., et al. (2012) · Oncogene · doi:10.1038/onc.2012.300 · Cited by 88
microRNAs Make the Call in Cancer Personalized Medicine
Detassis, S., Grasso, M., Vescovo, V. D., & Denti, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00086 · Cited by 88
Shaker, O. G., Maher, M., Nassar, Y., Morcos, G. N. B., & GAD, Z. A. (2015) · Gene · doi:10.1016/j.gene.2015.01.062 · Cited by 87
Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers
Deng, D., Liu, Z., & Du, Y. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00005-5 · Cited by 87
Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin
Yang, Z., Fang, S., Di, Y., Ying, W., Tan, Y. L., & Gu, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121547 · Cited by 87
miRNA-21 as a novel therapeutic target in lung cancer
Lianidou, E. S., Markou, A. N., & Zavridou, M. (2016) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s60341 · Cited by 88
Self-citationMicroRNAs and respiratory diseases
Rupani, H., Sánchez-Elsner, T., & Howarth, P. H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00212011 · Cited by 87
Tian, L., Qi, J., Oderinde, O., Yao, C., Song, W., & Wang, Y. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.03.045 · Cited by 85
MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells
Jiang, L., Huang, Q. M., Chang, J., Wang, E., & Qiu, X. (2011) · Experimental Lung Research · doi:10.3109/01902148.2010.492068 · Cited by 84
Tang, H., Zhu, J., Du, W., Liu, S., Zeng, Y., Ding, Z., Zhang, Y., Wang, X., Liu, Z., & Huang, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0811-6 · Cited by 83
Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.
Gao, J., Zhang, Q., Xu, J., Guo, L., & Li, X. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2013.12.04 · Cited by 99
Greene, S. B., Herschkowitz, J. I., & Rosen, J. M. (2010) · RNA Biology · doi:10.4161/rna.7.3.11837 · Cited by 84
MicroRNAs in clinical oncology: at the crossroads between promises and problems
Metias, S., Lianidou, E. S., & Yousef, G. M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064717 · Cited by 83
Self-citationIdentification of a new microRNA expression profile as a potential cancer screening tool
Roa, W., Brunet, B., Guo, L., Amanie, J., Fairchild, A. M., Gabos, Z., Nijjar, T. S., Scrimger, R. A., Yee, D., & Xing, J. Z. (2010) · Clinical and investigative medicine · doi:10.25011/cim.v33i2.12351 · Cited by 83
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications
Enfield, K. S. S., Pikor, L. A., Martínez, V. D., & Lam, W. L. (2012) · Genetics Research International · doi:10.1155/2012/737416 · Cited by 82
Mairinger, F. D., Ting, S. C., Werner, R., Walter, R. F. H., Hager, T., Vollbrecht, C., Christoph, D. C., Worm, K., Mairinger, T., Sheu‐Grabellus, S., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.74 · Cited by 81
Yuan, J., Chen, L., Chen, X., Sun, W., & Zhou, X. H. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000606 · Cited by 80
Ren, J., Zhu, D., Liu, M., Sun, Y., & Tian, L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.047 · Cited by 79
Alterations of MicroRNAs Contribute to Colon Carcinogenesis
Schetter, A. J., & Harris, C. C. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.08.009 · Cited by 78
Ou, H., Li, Y., & Kang, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109929 · Cited by 79
MicroRNAs in lung diseases: Recent findings and their pathophysiological implications
Ebrahimi, A., & Sadroddiny, E. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.08.007 · Cited by 77
Rask, L., Balslev, E., JØRGENSEN, S., Eriksen, J., Flyger, H. L., Møller, S., Høgdall, E. V. S., Litman, T., & Nielsen, B. S. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02782.x · Cited by 77
Gu, R., Liu, N., Luo, S., Huang, W., Zha, Z., & Yang, J. (2016) · Medicine · doi:10.1097/md.0000000000004315 · Cited by 77
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81
Epigenetics/epigenomics of triterpenoids in cancer prevention and in health
Li, S. N., Kuo, H. D., Yin, R., Wu, R., Liu, X., Wang, L., Hudlikar, R. R., Peter, R. M., & Kong, A. T. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113890 · Cited by 77
Jiang, L., Lv, X.-X., Li, J., Li, J., Li, X., Li, W., & Li, Y. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.11.001 · Cited by 76
MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis
Zhu, W., & Xu, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103373 · Cited by 75
MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment
Shah, N. R. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.48 · Cited by 76
Sputum MicroRNA Profiling: A Novel Approach for the Early Detection of Non-Small Cell Lung Cancer
Roa, W., Kim, J. O., Razzak, R., Du, H., Guo, L., Singh, R., Gazala, S., Ghosh, S., Wong, E. Y. L., Joy, A. A., et al. (2012) · Clinical and investigative medicine · doi:10.25011/cim.v35i5.18700 · Cited by 75
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer
Aharonov, R. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1403 · Cited by 75
Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients
Kim (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.430 · Cited by 75
MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer
Lee, J., Voortman, J., Dingemans, A. C., Voeller, D. M., Pham, T. C., Wang, Y., & Giaccone, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021300 · Cited by 73
Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
Tian, F., Shen, Y., Chen, Z., Li, R., Lu, J., & Ge, Q. (2016) · Gene · doi:10.1016/j.gene.2016.06.014 · Cited by 74
Du, W., Tang, H., Lei, Z., Zhu, J., Zeng, Y., Liu, Z., & Huang, J.-A. (2019) · Respiratory Research · doi:10.1186/s12931-019-1184-x · Cited by 74
Hu, A., Huang, J., Xu, W., Jin, X., Li, J., Tang, Y., Huang, X., Cui, H., & Sun, G.-B. (2014) · Europe PMC (PubMed Central) · Cited by 74
MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis
Wang, W., Li, J., Zhu, W. J., Gao, C., Jiang, R., Li, W., Hu, Q., & Zhang, B. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-819 · Cited by 74
Genetic and epigenetic changes in lung carcinoma and their clinical implications
Wen, J., Fu, J., Zhang, W., & Guo, M. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.46 · Cited by 77
Loss of microRNA-205 expression is associated with melanoma progression
Liu, S., Tetzlaff, M. T., Liu, A., Liegl-Atzwanger, B., Guo, J., & Xu, X. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.62 · Cited by 74
Guz, M., Rivero‐Müller, A., Okoń, E., Stenzel-Bembenek, A., Polberg, K., Słomka, M., & Stepulak, A. (2014) · Disease Markers · doi:10.1155/2014/218169 · Cited by 74
MicroRNAs in the Pathogenesis of Lung Cancer
Wu, X., Piper-Hunter, M. G., Crawford, M., Nuovo, G. J., Marsh, C. B., Otterson, G. A., & Nana-Sinkam, S. P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a99c77 · Cited by 72
Azzouzi, S., Fredj, Z., Turner, A. P. F., Ali, M. B., & Mak, W. C. (2019) · ACS Sensors · doi:10.1021/acssensors.8b00942 · Cited by 71
Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling
Katayama, Y., MAEDA, M., Miyaguchi, K., NEMOTO, S., Yasen, M., Tanaka, S., Mizushima, H., Fukuoka, Y., Arii, S., & Tanaka, H. (2012) · Oncology Letters · doi:10.3892/ol.2012.810 · Cited by 70
Wang, X., Wu, M., Liu, F., Li, Y., Li, N., Li, G., & Shen, S. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0582-7 · Cited by 69
Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer
Wang, X., Wang, W., Zhang, Z. D., Jing, Z., Xiao-Gang, T., & Jian-Chao, L. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-146 · Cited by 69
The role of miRNAs in Cancer: From Pathogenesis to Therapeutic Implications
Seven, M., Karataş, Ö. F., Düz, M. B., & Özen, M. (2014) · Future Oncology · doi:10.2217/fon.13.259 · Cited by 68
An, I., An, S., Kwon, K. J., KIM, Y. J., & Bae, S. (2012) · Oncology Reports · doi:10.3892/or.2012.2136 · Cited by 67
Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis
Xin Min, Z. H. O. U., Wang, X., Huang, Z., Wang, J., Zhu, W., Shu, Y., & Liu, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102413 · Cited by 67
Individual Au-Nanocube Based Plasmonic Nanoprobe for Cancer Relevant MicroRNA Biomarker Detection
Zhang, L., Wang, J., Zhang, J., Liu, Y., Wu, L., Shen, J., Zhang, Y., Hu, Y., Fan, Q., Huang, W., et al. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00322 · Cited by 67
Unique microRNA‐profiles in EGFR ‐mutated lung adenocarcinomas
Bjaanæs, M. M., Halvorsen, A. R., Solberg, S. K., Jørgensen, L. H., Dragani, T. A., Galvan, A., Colombo, F., Anderlini, M., Pastorino, U., Kure, E. H., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28828 · Cited by 65
Cao, H., Zhou, X. M., & Zeng, Y. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.09.121 · Cited by 65
MicroRNAs in the Regulation of MMPs and Metastasis
Abba, M. L., Patil, N., & Allgayer, H. (2014) · Cancers · doi:10.3390/cancers6020625 · Cited by 64
Potential role of micro‐RNAs in head and neck tumorigenesis
Tran, N., O’Brien, C. J., Clark, J. R., & Rose, B. R. (2010) · Head & Neck · doi:10.1002/hed.21356 · Cited by 64
Berghmans, T., Ameye, L., Willems, L., Paesmans, M., Mascaux, C., Lafitte, J., Meert, A. P., Scherpereel, A., Cortot, A. B., CsToth, I., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.020 · Cited by 64
Yang, J., Tang, M., Diao, W., Cheng, W., Zhang, Y., & Yan, Y. (2016) · Microchimica Acta · doi:10.1007/s00604-016-1958-5 · Cited by 64
Azzouzi, S., Mak, W. C., Kor, K., Turner, A. P. F., Ali, M. B., & Beni, V. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.02.014 · Cited by 61
Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer
Duncavage, E. J., Goodgame, B. W., Sezhiyan, A., Govindan, R., & Pfeifer, J. D. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f3909d · Cited by 62
He, Q., Cai, L., Shuai, L., Li, D., Wang, C., Liu, Y., Li, X., Li, Z., & Wang, S. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.21859 · Cited by 59
MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients
Zhou, H. F., Xiao, B., Zhou, F., Deng, H., Zhang, X., Lou, Y., Gong, Z., Du, C., & Guo, J. (2012) · Biomarkers · doi:10.3109/1354750x.2011.614961 · Cited by 59
Capodanno, A., Boldrini, L., Proietti, A., Alì, G., Pelliccioni, S., Niccoli, C., D’Incecco, A., Cappuzzo, F., Chella, A., Lucchi, M., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2003 · Cited by 59
Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
Tang, R., Liang, L., Luo, D., Feng, Z., Huang, Q., He, R., Gan, T., Yang, L., & Chen, G. (2015) · Medical Science Monitor · doi:10.12659/msm.894372 · Cited by 58
MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1
Lenarduzzi, M., Hui, A. B., Alajez, N. M., Shi, W., Williams, J. P., Yue, S., O’Sullivan, B., & Liu, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053765 · Cited by 58
The Prognostic Value of miR-21 and miR-155 in Non-small-cell Lung Cancer: A Meta-analysis
Wang, Y., Li, J., Tong, L., Zhang, J., Zhai, A., Xu, K., Wei, L., & Chu, M. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt084 · Cited by 60
Leidinger, P., Backes, C., Dahmke, I. N., Galata, V., Huwer, H., Stehle, I., Bals, R., Keller, A., & Meese, E. (2014) · Oncotarget · doi:10.18632/oncotarget.2419 · Cited by 54
Markou, A. N., Zavridou, M., Sourvinou, I. S., Yousef, G. M., Kounelis, S., Malamos, N., Georgoulias, V., & Lianidou, E. S. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.253716 · Cited by 58
Self-citationZhu, J., Zeng, Y., XU, C., Qin, H., Lei, Z., Shen, D., Liu, Z., & Huang, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4141 · Cited by 57
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
Markou, A. N., Liang, Y., & Lianidou, E. S. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.661 · Cited by 58
Self-citationTMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
Larzábal, L., de Aberasturi, A. L., Redrado, M., Rueda, P., Rodríguez, M. J., Bodegas, M. E., Montuenga, L. M., & Calvo, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.761 · Cited by 57
Bica, C., Pintea, S., Magdo, L., Cojocneanu, R., Gulei, D., Ferracin, M., & Berindan‐Neagoe, I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.516850 · Cited by 57
Wang, K., Chen, M., & Wu, W. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1244-y · Cited by 56
Szejniuk, W. M., Robles, A. I., McCulloch, T., Falkmer, S., & Røe, O. D. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-018-0029-1 · Cited by 56
The expression and function of miRNA-451 in non-small cell lung cancer
Wang, X., Tian, L.-L., Jiang, X., Wang, Y., Li, D., She, Y., Chang, J., & Meng, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.026 · Cited by 56
MicroRNA-21 is a novel promising target in cancer radiation therapy
Liu, J., Zhu, H., Yang, X., Ge, Y., Zhang, C., Qin, Q., Lü, J., Zhan, L., Cheng, H., & Sun, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-1623-8 · Cited by 56
Michailidi, C., Hayashi, M., Datta, S., Sen, T., Zenner, K., Oladeru, O. T., Brait, M., Izumchenko, E., Baras, A. S., VandenBussche, C. J., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0251 · Cited by 57
Zhang, J., Miao, X., Song, C., Chen, N., Xiong, J., Gan, H., Ni, J., Zhu, Y., Cheng, K., & Wang, L. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114379 · Cited by 54
The Emerging Role of Liquid Biopsies in Revolutionising Cancer Diagnosis and Therapy
Shegekar, T., Vodithala, S., & Juganavar, A. (2023) · Cureus · doi:10.7759/cureus.43650 · Cited by 57
Dijkstra, J. R., Mekenkamp, L. J. M., Teerenstra, S., De Krijger, I., & Nagtegaal, I. D. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01467.x · Cited by 53
MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer
Kang, S., Lee, H., & Cho, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.006 · Cited by 53
Lee, H. W., Lee, E. H., Ha, S. Y., Lee, C. H., Chang, H. K., Chang, S. H., Kwon, K. Y., Hwang, I., Roh, M. S., & Seo, J. (2012) · Pathology International · doi:10.1111/j.1440-1827.2012.02845.x · Cited by 53
Expression of miRNA-130a in Nonsmall Cell Lung Cancer
Wang, X., Du, L., Zhang, H., Wang, Y., Wu, H., Li, D., She, Y., Liu, Q., Fan, F., Meng, A., et al. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e892a0 · Cited by 52
Zhao, Y., Schetter, A. J., Yang, G. B., Nguyen, G. H., Mathé, E. A., Li, P., Cai, H., Yu, L., Liu, F., Hang, D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27954 · Cited by 52
Kesanakurti, D., Maddirela, D. R., Chittivelu, S., Rao, J. S., & Chetty, C. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.132 · Cited by 51
Li, L., Gan, H., Zhang, H., Tang, W., Sun, Y., Tang, X., Kong, D., Zhou, J., WANG, Y., & Zhu, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2312 · Cited by 52
MicroRNAs and lung cancers: from pathogenesis to clinical implications
Qi, J., & Mu, D. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0188-4 · Cited by 52
MicroRNA Hsa-miR-125a-3p Activates p53 and Induces Apoptosis in Lung Cancer Cells
Jiang, L., Chang, J., Zhang, Q., Sun, L., & Qiu, X. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.820314 · Cited by 52
Shen, K., Hung, J., Liao, Y.-C., Tsai, S., Wu, M., & Chen, P.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093080 · Cited by 53
Biomarkers for Smoking Cessation
Bough, K. J., Lerman, C. E., Rose, J. E., McClernon, F. J., Kenny, P. J., Tyndale, R. F., David, S. P., Stein, E. A., Uhl, G. R., Conti, D. V., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.57 · Cited by 51
Zeng, Y., Zhu, J., Shen, D., Qin, H., Lei, Z., Li, W., Huang, J., & Liu, Z. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3547 · Cited by 52
Chi, B., Liang, R., Qiu, W., Yuan, Y., & Qiu, J. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.042 · Cited by 50
The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer
Shen, Y., Pan, X., & Zhao, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.076 · Cited by 49
Hummel, R., Hussey, D. J., Michael, M., Haier, J., Bruewer, M., Senninger, N. J., & Watson, D. I. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1213-y · Cited by 50
MicroRNAs – Important Molecules in Lung Cancer Research
Leidinger, P., Keller, A., & Meese, E. U. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2011.00104 · Cited by 50
miR-21: A gene of dual regulation in breast cancer
Zhang, C., Liu, K., LI, T., Fang, J., Ding, Y., Sun, L., TU, T., JIANG, X., Du, S., Hu, J., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3232 · Cited by 52
Xu, Q., Ma, F., Huang, S., Tang, B., & Zhang, C. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00892 · Cited by 50
Du, Y., Du, S., Liu, L., Gan, F., Jiang, X., Wangrao, K., Lyu, P., Gong, P., & Yao, Y. (2020) · Radiation Research · doi:10.1667/rade-20-00019.1 · Cited by 53
Han, Q., Zhang, D., Zhang, R., Tang, J., Xu, K., Shao, M., Li, Y., Du, P., Zhang, R., Yang, D., et al. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131676 · Cited by 48
Rotunno, M., Zhao, Y., Bergen, A. W., Koshiol, J. E., Burdette, L. A., Rubagotti, M., Linnoila, R. I., Marincola, F. M., Bertazzi, P. A., Pesatori, A. C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605976 · Cited by 49
Kim, H., Yang, J. M., Jin, Y., Jheon, S., Kim, K., Lee, C. T., Chung, J.-H., & Paik, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14298 · Cited by 49
Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm
Yu, H., Chen, X., & Lu, L. (2017) · Scientific Reports · doi:10.1038/srep43792 · Cited by 49
microRNA regulation of cell viability and drug sensitivity in lung cancer
Du, L., & Pertsemlidis, A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.697149 · Cited by 49
Metadata
- Authors
- Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Sotiria General Hospital (GR)
- Onassis Cardiac Surgery Center (GR)
- University of Crete (GR)
- Corresponding author
- Lianidou, Evi S
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 54
- Issue
- 10
- Pages
- 1696-1704
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2154551754
- Cited by
- 441
- References
- 39
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 21 · 2018: 18 · 2017: 31 · 2016: 26 · 2015: 34 · 2014: 42 · 2013: 33 · 2012: 51
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National and Kapodistrian University of Athens
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- miR-21, microRNA-205, non-small cell lung cancer, prognostic factors, microRNA overexpression, overall survival, tumor recurrence, microRNA quantification
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Prognosis, Multivariate Analysis, Survival Analysis, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review